CD19 and melanoma: This process resulted in a cohort of a total of 48 melanoma patients comprising 30 NRs and 18 Rs. In this setting, we found distinct clusters of the immune cell compartment comprising mainly CD4 + T-cells, CD8 + T-cells, NK and B-cells (CD19 +/CD20 +).